Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
Efficient deconvolution of antibody targets is needed for phenotype-based discovery. Here, the authors investigate a deconvolution approach based on pooled CRISPR Cas9 to achieve 97% deconvolution success rate.
Guardado en:
Autores principales: | Jenny Mattsson, Ludvig Ekdahl, Fredrik Junghus, Ram Ajore, Eva Erlandsson, Abhishek Niroula, Maroulio Pertesi, Björn Frendéus, Ingrid Teige, Björn Nilsson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e2a5135b9de48a8b79f53b16495e80f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk
por: Laura Duran-Lozano, et al.
Publicado: (2021) -
Deconvoluting hepatic processing of carbon nanotubes
por: Simone Alidori, et al.
Publicado: (2016) -
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
por: Mina Ali, et al.
Publicado: (2018) -
Single-Cell Approaches to Deconvolute the Development of HSCs
por: Yang Xiang, et al.
Publicado: (2021) -
A nanofluidic device for parallel single nanoparticle catalysis in solution
por: Sune Levin, et al.
Publicado: (2019)